1.5 tirzepatide Appetite Suppression Timeline: What to Expect at Each Stage Tirzepatide Dosage Chart: Weekly Dosing

See our Important Safety Information for full details

No retatrutide does not currently hold a marketing authorisation from the MHRA or EMA and is not legally available as a prescribed treatment in the UK outside of authorised clinical trials

Nevertheless, any new or worsening hair loss during treatment warrants discussion with a GP or prescriber to rule out other contributing causes, such as nutritional deficiencies or thyroid dysfunction

By leveraging such technology, patients can better understand their medication options, including cost implications, side effects, and lifestyle considerations, empowering them to make informed decisions alongside their healthcare providers

Rashes and itching are possible but uncommon